Array Technologies Inc
(NASDAQ: ARRY)

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs to treat patients afflicted with cancer and inflammatory diseases. The drug development pipeline includes clinical candidates that are designed to regulate therapeutically important target pathways. The Company�s drug candidates include AMG 151, MEK162, ARRY-380, ARRY-520, ARRY-543 and ARRY-614.

7.550 -

+0.320 (+4.43%)
Jarak 7.350 - 7.620   (3.67%)
Buka 7.350
Tutup Terdahulu 7.230
Harga Beli -
Beli Purata -
Jual Beli -
Purata Jual -
Purata 3,765,968
Nilai 23,467,402
Catatan -
Harga tertunda. Dikemas kini pada 02 Apr 2026 08:15.
Data dikuasakan oleh
Lihat Semua Acara

Mengenai Array Technologies

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of small molecule drugs to treat patients afflicted with cancer and inflammatory diseases. The drug development pipeline includes clinical candidates that are designed to regulate therapeutically important target pathways. The Company�s drug candidates include AMG 151, MEK162, ARRY-380, ARRY-520, ARRY-543 and ARRY-614.

Loading Chart...

Please login to view stock data and analysis